QUIDELORTHO CORP Earnings Per Share (Basic)
QUIDELORTHO CORP (QDEL) reported Earnings Per Share (Basic) of -$1.36 per share for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- QUIDELORTHO CORP earnings per share, basic for the quarter ending 2026-06-28 was -$1.36.
- QUIDELORTHO CORP earnings per share, basic for the quarter ending 2026-03-29 was -$1.35.
- QUIDELORTHO CORP earnings per share, basic for the quarter ending 2025-12-28 was -$1.92.
- QUIDELORTHO CORP earnings per share, basic for the quarter ending 2025-09-28 was -$10.78.
- QUIDELORTHO CORP earnings per share, basic for fiscal 2025 was -$16.69.
- QUIDELORTHO CORP earnings per share, basic for fiscal 2024 was -$30.54.
- QUIDELORTHO CORP earnings per share, basic for fiscal 2023 was -$0.15, a 101.55% decline from fiscal 2023.
- QUIDELORTHO CORP earnings per share, basic for fiscal 2023 was $9.66, a 42.29% decline from fiscal 2022.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-28 | -$1.36 10-Q · filed 2026-08-07 | -$2.71 10-Q · filed 2026-08-07 | -$4.62 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$15.38 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2026-03-29 | -$1.35 10-Q · filed 2026-05-06 | -$3.26 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$14.03 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$17.81 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-12-28 | -$1.92 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$12.69 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$16.47 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$16.69 10-K · filed 2026-02-19 |
| 2025-09-28 | -$10.78 10-Q · filed 2025-11-06 | -$14.57 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$14.79 10-Q · filed 2025-11-06 | -$17.43 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-06-29 | -$3.77 10-Q · filed 2026-08-07 | -$3.97 10-Q · filed 2026-08-07 | -$6.61 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$6.91 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-03-30 | -$0.19 10-Q · filed 2026-05-06 | -$2.83 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$3.13 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$5.33 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2024-12-29 | -$2.64 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$2.94 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$5.14 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$30.54 10-K · filed 2026-02-19 |
| 2024-09-29 | -$0.30 10-Q · filed 2025-11-06 | -$2.49 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$27.92 10-Q · filed 2025-11-06 | -$27.85 derived: net income ÷ weighted average shares · filed 2026-04-27 |
| 2024-06-30 | -$2.20 10-Q · filed 2025-08-06 | -$27.67 10-Q · filed 2025-08-06 | -$27.59 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$27.78 derived: net income ÷ weighted average shares · filed 2026-04-27 |
| 2024-03-31 | -$25.50 10-Q · filed 2025-05-08 | -$25.42 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$25.60 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$26.40 derived: net income ÷ weighted average shares · filed 2026-04-27 |
| 2023-12-31 | $0.10 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$0.15 10-K · filed 2026-02-19 |
| 2023-10-01 | -$0.19 10-Q · filed 2024-11-08 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$0.26 10-Q · filed 2024-11-08 | $0.20 derived: net income ÷ weighted average shares · filed 2026-04-27 |
| 2023-07-02 | -$0.80 10-Q · filed 2024-08-01 | -$0.07 10-Q · filed 2024-08-01 | $0.39 derived: net income ÷ weighted average shares · filed 2026-04-27 | $0.68 derived: net income ÷ weighted average shares · filed 2026-04-27 |
| 2023-04-02 | $0.73 10-Q · filed 2024-05-09 | $1.19 derived: net income ÷ weighted average shares · filed 2026-04-27 | $1.48 derived: net income ÷ weighted average shares · filed 2026-04-27 | $1.87 derived: net income ÷ weighted average shares · filed 2026-04-27 |
| 2023-01-01 | $0.46 derived: net income ÷ weighted average shares · filed 2026-04-27 | $0.74 derived: net income ÷ weighted average shares · filed 2026-04-27 | $1.11 derived: net income ÷ weighted average shares · filed 2026-04-27 | $9.66 10-K · filed 2025-02-27 |
| 2022-10-02 | $0.29 10-Q · filed 2023-11-02 | $0.65 derived: net income ÷ weighted average shares · filed 2023-11-02 | $9.67 10-Q · filed 2023-11-02 | $15.85 derived: net income ÷ weighted average shares · filed 2026-04-27 |
| 2022-07-03 | $0.37 10-Q · filed 2023-08-09 | $10.62 10-Q · filed 2023-08-09 | $17.26 derived: net income ÷ weighted average shares · filed 2026-04-27 | $22.47 derived: net income ÷ weighted average shares · filed 2026-04-27 |
| 2022-04-03 | $11.46 10-Q · filed 2023-05-04 | $18.10 derived: net income ÷ weighted average shares · filed 2026-04-27 | $23.33 derived: net income ÷ weighted average shares · filed 2026-04-27 | $23.87 derived: net income ÷ weighted average shares · filed 2026-04-27 |
| 2022-01-02 | $6.73 derived: net income ÷ weighted average shares · filed 2026-04-27 | $11.93 derived: net income ÷ weighted average shares · filed 2026-04-27 | $12.46 derived: net income ÷ weighted average shares · filed 2026-04-27 | $16.74 10-K/A · filed 2024-08-01 |
| 2021-10-03 | $5.17 10-Q · filed 2022-11-04 | $5.63 derived: net income ÷ weighted average shares · filed 2022-11-04 | $9.91 10-Q · filed 2022-11-04 | |
| 2021-07-04 | $0.46 10-Q · filed 2022-08-05 | $4.74 10-Q · filed 2022-08-05 | ||
| 2021-01-03 | $19.24 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |